Gene mutations in lung cancer: promising predictive factors for the success of molecular therapy.
Inoue
Akira
A
Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan. akinoue@idac.tohoku.ac.jp
Nukiwa
Toshihiro
T
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics*; D004252:DNA Mutational Analysis; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D066246:ErbB Receptors / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011237:Predictive Value of Tests; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D066246:ErbB Receptors